A hollow balloon and related systems and methods

By designing hollow balloon assembly and catheter assembly, using multiple sub-balloons and compliant rings to form fluid channels, combined with drug coating, the acute rebound and dissection of blood vessel walls in existing interventional treatments is solved, and long-term support intravascular space is achieved and the continuous effect of the drug improves the therapeutic effect.

CN117643678BActive Publication Date: 2024-12-03SHANGHAI HOPE MEDICAL DEVICES CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410114383.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-29
Publication Date
2024-12-03
Estimated Expiration
2044-01-29

AI Technical Summary

Technical Problem

In existing interventional treatment, drug-eluting stents and bioabsorbable stents have problems with inflammatory responses, restenosis and poor mechanical properties, while drug-eluting balloons last for a short duration on the blood vessel wall, resulting in acute rebound and Dissection is at high risk and cannot effectively solve the long-term problem of vascular stenosis.

Method used

A hollow balloon is designed, including a balloon assembly and a catheter assembly. The balloon assembly is composed of multiple sub-balloons and compliant rings to form a fluid channel. The catheter assembly has a fluid injection channel and a drug coating, which can be used for a long time in the blood vessel. Support the blood vessel wall to avoid acute rebound and dissection.

Benefits of technology

Hollow balloons can continuously support the blood vessel wall in the blood vessel for a long time, reduce the risk of acute rebound and dissection, improve the treatment effect, prolong the drug action time, and reduce the occurrence of complications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117643678B_ABST
    Figure CN117643678B_ABST
Patent Text Reader

Abstract

The present invention relates to a hollow balloon, comprising a balloon assembly and a catheter assembly, wherein the balloon assembly comprises a balloon body, the balloon body comprises a sub-balloon, a flexible ring and a receiving port; all sub-balloons and the flexible ring are sequentially connected to each other, and all sub-balloons and the flexible ring are coaxially arranged, so that the inner hollow structures of all sub-balloons and the flexible ring together constitute a fluid channel; the catheter assembly comprises a connecting tube, a traction rope, a through tube and a joint; the distal ends of the traction rope and the connecting tube are arranged at the proximal end of the balloon body and are circumferentially cross-arranged with the receiving port, the proximal ends of the traction rope and the connecting tube are gathered together and connected with the distal end of the through tube, and the proximal end of the through tube is connected to the joint; an injection channel is provided on the catheter assembly, and the injection channel is connected with all sub-balloons. When the hollow balloon is used, the drug coating on the surface of the balloon assembly is continuously absorbed by the blood vessel wall, and the balloon assembly can also support the blood vessel wall for a long time to avoid acute rebound and acute dissection of the vessel wall.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medical devices and relates to a hollow balloon. Background Art

[0002] Peripheral vascular diseases (PVD), classified by anatomical location, usually refer to arterial and venous diseases other than coronary arteries, heart valves, and intracranial blood vessels, such as the aorta and its branches, arteries and veins of the limbs, vena cava, portal vein system, etc. The main types of peripheral vascular diseases include: stenotic occlusive diseases, dilatative diseases, and developmental abnormalities. For patients with mid- and late-stage stenotic occlusive lesions, intravascular interventional treatment is usually required to achieve significant improvement. The current mainstream interventional products for the treatment of vascular stenosis include: drug-eluting stents, bioresorbable stents, drug-eluting balloons, etc.

[0003] Drug-eluting stents (DES) are a type of stent that is coated with some drugs with anticoagulant and / or anti-tissue cell proliferation combined with drug-loaded polymers on bare metal stents, which are eluted and released locally in the blood vessels to prevent in-stent restenosis. Compared with simple balloon dilatation and bare metal stents, DES can significantly reduce the occurrence of in-stent restenosis. However, since this type of stent is a permanent implant, as the stent remains in the blood vessel for a longer time, it may cause inflammatory reactions and hypersensitivity reactions at the implantation site. The drugs carried on the stent (such as rapamycin, paclitaxel, etc.) inhibit smooth muscle cell proliferation while delaying the re-endothelialization of the injured vascular site, which can lead to catastrophic late in-stent thrombosis.

[0004] The original intention of designing bioresorbable vascular scaffolds (BVS) is to hope that after the stent is implanted into the stenosis and releases the proliferative drug, it can gradually degrade and be completely absorbed by the tissue while providing temporary vascular support, so that the vascular structure can be restored to a normal physiological state. The biggest advantage of this type of stent is that it leaves no trace in the body. From the current relevant survey, although a number of BVS have been approved for marketing, the latest long-term follow-up results are not satisfactory. Its main disadvantages include: in addition to the high R&D cost, foreign body residue, restenosis in the stent, poor mechanical properties, severe elastic retraction, and complications such as chronic inflammatory reactions. Therefore, the absorbable stent technology is not yet mature, and the long-term effect still needs further evaluation.

[0005] Drug eluting balloon (DEB) refers to a traditional balloon with some anti-proliferative drugs coated on its surface. It mainly achieves the effect of inhibiting vascular intimal hyperplasia locally by making the drugs on the balloon surface contact with the diseased blood vessels temporarily through balloon expansion, and then quickly releasing them into the blood vessel wall. Compared with DES, the main advantages of DEB are: ① DEB can release drugs more evenly into the arterial wall; ② No polymers and metal residues, thus reducing the incidence of inflammatory response and late thrombosis; ③ It significantly shortens the duration of dual antiplatelet therapy and reduces the occurrence of related complications. Although DEB has shown great prospects in interventional treatment, it also has some defects: ① Acute wall rebound. Since the continuous action time of DEB on the blood vessel wall is usually 1~3min, after the balloon is withdrawn, the skeleton support is lost and the wall rebounds acutely, which cannot fully expand the stenosis lesion to relieve the stenosis, resulting in a residual stenosis rate that is usually higher than that of the stent; ② Acute dissection occurs. Any type of balloon dilatation may cause vascular dissection or tear, so DEB should be used with caution, especially for main branch vessels or dominant vessels. If vascular dissection or tear is not discovered in time, the result may be catastrophic if acute thrombosis or vascular occlusion occurs after surgery. Summary of the invention

[0006] The invention discloses a hollow balloon, aiming to solve some technical problems existing in existing products.

[0007] The present invention adopts the following technical solutions:

[0008] A hollow balloon, comprising:

[0009] A balloon assembly, the balloon assembly comprises a balloon body and a developing element, the balloon body comprises a plurality of sub-balloons, a plurality of flexible rings and a plurality of receiving ports; the sub-balloons are hollow cylindrical structures, the flexible rings are hollow annular structures, and the flexible rings are provided with a plurality of through holes; all the sub-balloons and the flexible rings are sequentially connected to each other, and all the sub-balloons and the flexible rings are coaxially arranged, so that the hollow structures of all the sub-balloons and all the flexible rings together constitute the fluid channel of the balloon body; the receiving port is arranged on the proximal edge of the balloon body; the outer surface of the balloon assembly is provided with a drug coating;

[0010] A catheter assembly, the catheter assembly includes a connecting tube, a plurality of traction ropes, a through tube and a joint; the distal end of the connecting tube is arranged on the proximal edge of the balloon body, and is interconnected and communicated with the balloon body, and the proximal end of the connecting tube is connected and communicated with the distal end of the through tube; the distal end of each of the traction ropes is arranged on the proximal edge of the balloon body, so that the distal end of the connecting tube and each of the connection points of the distal end of each of the traction ropes are respectively arranged circumferentially cross-arranged with the receiving port in sequence, the proximal end of each of the traction ropes and the proximal end of the connecting tube are gathered together and connected to the distal end of the through tube, and the proximal end of the through tube is connected to the joint; an injection channel is provided on the catheter assembly, and the injection channel is communicated with the inner cavity of all the sub-balloons and the through holes on all the flexible rings; the outer surface of the catheter assembly is provided with a drug coating.

[0011] In an optional embodiment, the drug coating on the outer surface of the balloon component and the catheter component includes but is not limited to at least one of paclitaxel and rapamycin.

[0012] In an optional embodiment, the balloon assembly further includes a developing element, which is disposed at both ends of the balloon body and is used to mark the position of the balloon assembly.

[0013] In an optional embodiment, the balloon body is a tubular structure composed of a distal end of a hollow cylinder circumferentially connected to the proximal end of a flexible ring, and the distal end of the flexible ring is circumferentially connected to the proximal end of the next hollow cylinder, and similarly, other flexible rings and hollow cylinders are alternately connected end to end in sequence; each hollow cylinder constitutes a sub-balloon; each sub-balloon is also provided with an inner cavity, and all the inner cavities and all the through holes together constitute a filling cavity.

[0014] In an optional embodiment, the compliant ring is a hollow annular structure, the through hole is located on the ring of the compliant ring, the opening direction of the through hole is consistent with the opening of the compliant ring, and the through hole intersects or is tangent to the ring of the compliant ring.

[0015] In an optional embodiment, the number of the through holes on each of the compliant rings is not less than 2.

[0016] In an optional embodiment, the storage opening is in a C-shape, a V-shape, a rectangle or a square, and the number of the storage openings is not less than 3.

[0017] In an optional embodiment, the material of the balloon component and the catheter component includes but is not limited to at least one of nylon (PA), polyether block polyamide (Pebax), polyurethane (PU) or polyethylene terephthalate (PET).

[0018] In an optional embodiment, the outer diameter of the balloon body is 5~25mm; the length of the balloon body is 10~200mm; the cross-sectional diameter of the inner cavity of the sub-balloon is 0.5~2mm; the cross-sectional diameter of the through hole is 0.5~2mm; and the length of the through hole is 0.5~5mm.

[0019] In an optional embodiment, the diameter of each traction rope is not larger than the outer diameter of the connecting tube, the outer diameter of the connecting tube is not larger than the outer diameter of the through tube, the outer diameter of the through tube is the same as the diameter of the joint, and the diameter of the joint is smaller than the diameter of the fluid channel.

[0020] In an optional embodiment, the traction rope is a solid strip structure, and the number of the traction ropes is not less than 2.

[0021] In an optional embodiment, the number of the connecting pipes is not less than one.

[0022] In an optional embodiment, a rubber plug is provided in the joint, and the rubber plug is tightly combined with the inner cavity of the joint.

[0023] In an optional embodiment, the diameter of each of the sub-balloons on the balloon assembly is the same. Similarly, the diameter of each of the flexible rings is the same, that is, the channel diameters of each section of the entire fluid channel are the same.

[0024] In an optional embodiment, the diameter of each sub-balloon on the balloon assembly is different. Similarly, the diameter of each flexible ring is different, that is, the channel diameters of each section of the entire fluid channel are different.

[0025] In an optional embodiment, the balloon body only includes multiple sub-balloons, and the balloon body is a spiral structure formed by a long original balloon spirally wound around a central axis, each spiral circle of the spiral structure constitutes a sub-balloon, and all the sub-balloons are interconnected; the sub-balloons are hollow ring-shaped structures, and all the sub-balloons are coaxially arranged, so that the inner circles of all the sub-balloons together constitute the fluid flow channel of the balloon body.

[0026] Compared with the prior art, the technical solution adopted by the present invention has the following advantages:

[0027] The aforementioned hollow balloon includes a balloon assembly and a catheter assembly, wherein the balloon assembly includes a balloon body, and the balloon body includes a sub-balloon, a flexible ring and a receiving port; all the sub-balloons and the flexible rings are connected to each other in sequence, and all the sub-balloons and the flexible rings are coaxially arranged so that the inner hollow structures of all the sub-balloons and the flexible rings form a fluid channel; the catheter assembly includes a connecting tube, a traction rope, a through tube and a joint; the distal ends of the traction rope and the connecting tube are arranged at the proximal end of the balloon body and are circumferentially cross-arranged with the receiving port, the proximal ends of the traction rope and the connecting tube are gathered together and connected to the distal end of the through tube, and the proximal end of the through tube is connected to the joint; the catheter assembly is provided with an injection channel, and the injection channel is connected to all the sub-balloons. When the technical solution of the present invention is implemented, after the hollow balloon is delivered to the diseased blood vessel and is filled and fully expanded by the filling agent, the drug coating on the balloon assembly can be contacted by the blood vessel wall at the diseased site and fully and continuously absorbed, while the fluid channel allows blood to flow normally through the fluid channel, and the drug coating on the surface of the catheter assembly can prevent thrombus formation on the surface of the catheter assembly. Furthermore, the balloon assembly can be placed at the location of the vascular lesion for a long period of time, so that the balloon assembly can continue to support the blood vessel wall for a long time, thereby avoiding acute rebound and acute dissection of the blood vessel wall. Therefore, while improving the treatment effect, it also prevents the occurrence of unnecessary complications. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] The following drawings are simple schematic diagrams, which are intended to more clearly illustrate the technical solutions of the embodiments of the present invention and do not constitute improper limitations on the present invention. In the drawings:

[0029] Figure 1 A schematic diagram of the partial structure of the hollow balloon provided in Example 1 of the present invention when fully expanded;

[0030] Figure 2 for Figure 1 A local enlarged schematic diagram of the middle A;

[0031] Figure 3 for Figure 1 Schematic diagram of the cross section of the middle balloon when fully expanded;

[0032] Figure 4 This is a partial schematic diagram of a hollow balloon provided in an embodiment of Example 1 of the present invention being compressed and assembled in a delivery device;

[0033] Figure 5 yes Figure 1 Schematic diagram of application scenarios of the hollow balloon shown;

[0034] Figure 6 yes Figure 1A schematic diagram of an implementation scenario in which the proximal end portion of the catheter assembly of the hollow balloon is fixed outside the body;

[0035] Figure 7 A partial schematic diagram of a balloon recovery device provided in one embodiment of Example 1 of the present invention;

[0036] Figure 8 A schematic diagram of a process for deploying and recovering a hollow balloon in a patient's vascular system provided in one implementation of Example 1 of the present invention;

[0037] Fig. 9 A schematic diagram of the local structure of a hollow balloon provided in one embodiment of Example 2 of the present invention when fully expanded;

[0038] Fig.10 for Fig. 9 Schematic diagram of the cross section of the balloon when fully expanded.

[0039] Description of reference numerals:

[0040] Balloon assembly 100, balloon body 110, sub-balloon 111, flexible ring 112, through hole 113, developing element 120, receiving port 130, filling cavity 140, fluid channel 150, catheter assembly 200, joint 210, rubber plug 211, through tube 220, injection channel 221, connecting tube 230, traction rope 240, delivery device 300, TIP head 310, delivery catheter 320, loading sleeve 330, butterfly buckle 410, sterile dressing 420, recovery device 500, outer tube 510, inner tube 520, receiving net 530, balloon assembly 100', balloon body 110', sub-balloon 111111', developing element 120', filling cavity 140', fluid channel 150', connecting tube 230', traction rope 240'. Implementation

[0041] In order to make the purpose, advantages and technical solutions of the present invention clearer, the embodiments of the present invention will be further described in detail and completely in conjunction with the accompanying drawings. Without departing from the spirit of the present invention, the details in this specification can be modified or changed as necessary according to actual needs. It should be noted that in the description of the present invention, the accompanying drawings only illustrate the basic concept of the present invention in a schematic manner, and the schematic diagram only shows the components related to the present invention, and is not drawn according to the number, shape and size of the components during actual implementation. The number, shape and proportion of each component during actual implementation can be changed accordingly according to needs. In addition, each embodiment of the present description has one or more technical features, which does not mean that the user of the present invention must implement all the technical features in any embodiment at the same time, or can only implement part or all of the technical features in different embodiments separately. That is to say, those skilled in the art can selectively implement some or all of the technical features in any embodiment of the disclosure in the present invention according to actual needs, or selectively implement a combination of some or all of the technical features in multiple embodiments, thereby making the present invention more flexible when implemented.

[0042] In the description of the present invention, it should also be noted that the term "or" is usually used in a sense including "and / or", unless the content clearly indicates otherwise. Unless otherwise clearly stipulated and limited, the terms "installed", "connected", and "connected" should be understood in a broad sense. For example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium, and it can be the internal connection of two elements or the interaction relationship between two elements. In this article, the term "distal end" refers to the end of the medical device that first enters the patient's body during normal use, and the "proximal end" is the end close to the operator. For those of ordinary skill in the art, the specific meanings of the above terms in the present invention can be understood according to the specific circumstances.

[0043] The embodiments described in the present invention are only a part of the embodiments, not all of the embodiments. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention. Example

[0044] This embodiment 1 provides a hollow balloon to solve the problems existing in the prior art. Figure 1 to Figure 7In a preferred embodiment, the hollow balloon includes a balloon assembly 100 and a catheter assembly 200; wherein the balloon assembly 100 includes a balloon body 110 and a developing element 120, the balloon body 110 includes a plurality of sub-balloons 111, a plurality of flexible rings 112 and a plurality of receiving ports 130; the sub-balloons 111 are hollow cylindrical structures, the flexible rings 112 are hollow annular structures, and the flexible rings 112 are provided with a plurality of through holes. 113; all the sub-balloons 111 and the flexible rings 112 are connected to each other in sequence, and all the sub-balloons 111 and the flexible rings 112 are coaxially arranged, so that the inner hollow structures of all the sub-balloons 111 and all the flexible rings 112 together constitute the fluid channel 150 of the balloon body 110, and the fluid channel 150 axially penetrates the balloon body 110; the receiving port 130 is arranged on the proximal edge of the balloon body 110; the outer surface of the balloon assembly 100 is provided with a drug coating; The catheter assembly 200 includes a connecting tube 230, a plurality of traction ropes 240, a through tube 220, and a joint 210; the distal end of the connecting tube 230 is arranged on the proximal edge of the balloon body 110, and the connecting tube 230 and the balloon body 110 are connected and communicated with each other, and the proximal end of the connecting tube 230 is connected and communicated with the through tube 220; the distal end of each traction rope 240 is arranged on the proximal edge of the balloon body 110, so that the distal end of the connecting tube 230 and each traction rope 240 are connected. 0 are arranged circumferentially and crosswise with the receiving port 130 in sequence, the proximal end of each traction rope 240 and the proximal end of the connecting tube 230 are gathered together and connected with the distal end of the through tube 220, and the proximal end of the through tube 220 is connected to the joint 210; the catheter assembly 200 is also provided with an injection channel 221, and the injection channel 221 is connected with the through holes 113 on all the sub-balloons 111 and all the flexible rings 112; the outer surface of the catheter assembly 200 is provided with a drug coating.

[0045] Since the hollow balloon has a unique design structure and innovative treatment concept, it is not only suitable for patients with in-stent restenosis and bleeding risks, but also for patients with medium and large diseased blood vessels, such as patients with Budd-Chiari syndrome. This fills the gap in the interventional treatment of medium and large diseased blood vessels with ordinary drug balloons.

[0046] In a preferred embodiment, the balloon body 110 is first made of nylon (PA), polyether block polyamide (Pebax), polyurethane (PU) or polyethylene terephthalate (PET) as a raw material, and is stretched, blown and extruded on a specific mold to form a hollow cylinder with an inner cavity. The hollow cylinder is then placed on another specific mold and annularly extruded and bonded at multiple locations. The cavity on the ring that is not extruded constitutes a through hole 113, and the through hole 113 at one location and the extruded cavity constitute a through hole 113. The bonded parts together form a flexible ring 112, and the two ends of an annular extruded bonded part along the length direction of the cylinder form a sub-balloon 111 on both ends of the flexible ring 112, and finally form a one-piece balloon body 110 with multiple sub-balloons 111 and multiple flexible rings 112 interconnected; the inner cavities of all sub-balloons 111 and the through holes 113 on the flexible ring 112 together form the filling cavity 140 of the balloon body 110, and the filling cavity 140 is isolated from the fluid channel 150. When the filling agent is injected into the balloon body 110, the balloon body 110 will expand radially outward so that the outer wall of the balloon body 110 fits the inner wall of the blood vessel.

[0047] Furthermore, the relative positions of the sub-balloons 111 and the flexible rings 112 are arranged as follows: proximal sub-balloon 111 No. 1 - flexible ring 112 No. 1 - sub-balloon 111 No. 2 - flexible ring 112 No. 2 - ... - flexible ring 112 No. n-1 - distal sub-balloon 111 No. n, arranged in sequence, that is, the sub-balloons 111 and the flexible rings 112 are arranged crosswise in sequence, if the number of sub-balloons 111 is n, then there are n-1 flexible rings 112, that is, the number of flexible rings 112 is always one less than that of the sub-balloons 111.

[0048] Optionally, the length of each sub-balloon 111 can be consistent or different, and the arrangement of each flexible ring 112 on the balloon body 110 can be equidistant or unequal, and the through hole 113 on the flexible ring 112 can be one or more, and the through hole 113 is interconnected with the inner cavity of the connected sub-balloon 111, and the other extruded and bonded parts of the flexible ring 112 except the through hole 113 are not connected with the connected sub-balloon 111, that is, the filling agent can continue to fill the next sub-balloon 111 through the through hole 113 while filling the inner cavity of one sub-balloon 111; because the flexible ring 112 is annular and thin-walled (except for the through hole 113), the sub-balloons 111 at both ends of the flexible ring 112 have a larger free bending space, and its working principle is similar to that of a universal tube, so the flexibility of the entire balloon body 110 is significantly improved due to the action of the flexible ring 112, and the outer surface of the balloon body 110 can better fit the blood vessel wall;

[0049] Optionally, the diameter of each sub-balloon 111 on the balloon assembly 100 is the same, and similarly, the diameter of each flexible ring 112 is the same, that is, the channel diameters of each section of the entire fluid channel 150 are the same; the diameter of each sub-balloon 111 on the balloon assembly 100 is different, and similarly, the diameter of each flexible ring 112 is different, that is, the channel diameters of each section of the entire fluid channel 150 are different; specifically, during the actual design, the appropriate length of the balloon body 110 and the arrangement of the sub-balloons 111 and the flexible rings 112 can be selected based on imaging observations of the lesion site so that they can fully fit the blood vessel wall.

[0050] Furthermore, a plurality of receiving ports 130 are formed at the edge of the sub-balloon 111 at the distal end of the connection tube 230 and the traction rope 240. Each receiving port 130 is arranged in a ring at a certain interval along the edge of the sub-balloon 111, and a traction rope 240 or a connection tube 230 is connected between every two adjacent receiving ports 130. The receiving port 130 is in a C-shape, a V-shape, a rectangle or a square. The receiving port 130 is a part of the edge of the proximal sub-balloon 111, and its formation method can be achieved by placing the edge of one end of the sub-balloon 111 on another specific mold and inserting it into the mold. Circular extrusion and bonding are performed to remove excess material to form a hollow receiving port 130; preferably, the number of receiving ports 130 is 3 or more, and the size can be adjusted according to the diameter of the sub-balloon 111. For example, if the diameter of the sub-balloon 111 is relatively large, the receiving port 130 should also be enlarged so that the sub-balloon 111 and the receiving port 130 can be better matched; the receiving port 130 is designed to prevent the occurrence of a "dog bone effect" in the proximal end of the balloon body 110 after collapse and flattening, so as to facilitate the recovery of the balloon body 110.

[0051] Furthermore, in addition to the balloon body 110, the balloon assembly 100 also includes a developing element 120 made of an X-opaque material. The developing element 120 is arranged at both ends of the balloon body 110 to determine whether the balloon assembly 100 reaches the lesion location during use of the hollow balloon.

[0052] Optionally, the outer diameter of the balloon body 110 is 5-25 mm; the length of the balloon body 110 is 10-200 mm; the cross-sectional diameter of the inner cavity of the sub-balloon 111 is 0.5-2 mm; and the cross-sectional diameter of the through hole 113 is 0.5-2 mm. Specifically, due to individual differences between different patients, their lesions may have different shapes or sizes, so the size and arrangement of the balloon body 110 can be selected according to actual conditions.

[0053] In a preferred embodiment, the catheter assembly 200 includes a connecting tube 230, a traction rope 240, a through tube 220 and a connector 210, wherein the materials used to make the connecting tube 230, the traction rope 240 and the through tube 220 include but are not limited to at least one of nylon (PA), polyether block polyamide (Pebax), polyurethane (PU) or polyethylene terephthalate (PET); the connector 210 is made of acrylonitrile-butadiene-styrene copolymer (ABS), and the rubber plug 211 in the connector 210 is made of medical rubber.

[0054] Optionally, a hydrophilic coating (not shown in the figure) is further provided on the outer surface of the catheter assembly 200. The hydrophilic coating can make the outer surface of the catheter assembly 200 have good hydrophilicity and lubricity, and can inhibit the adsorption of cells and proteins on the surface, thereby reducing the resistance of relative sliding between the outer surface of the catheter assembly 200 and the blood vessel wall and the matching device.

[0055] Furthermore, the connecting tube 230 is a continuous hollow pipe, which is a part of the injection channel 221. The distal end of the connecting tube 230 is connected and communicated with the proximal wall of the balloon body 110 along the circumference of the balloon body 110, and is specifically located between any two adjacent receiving ports 130. The proximal end of the connecting tube 230 is connected and communicated with the distal end of the through tube 220. The number of connecting tubes 230 arranged on the balloon body 110 may be one or more, and the outer diameter of the connecting tube 230 is not greater than the outer diameter of the through tube 220.

[0056] Furthermore, the traction rope 240 is a solid strip structure, the proximal ends of all the traction ropes 240 are gathered together and connected to the distal end of the through tube 220, the distal ends of all the traction ropes 240 are connected to the proximal wall of the balloon body 110 along the circumference of the balloon body 110, and are alternately arranged with the receiving port 130 in sequence; the number of traction ropes 240 is 2 or more, and the diameter of the traction rope 240 is not greater than the outer diameter of the connecting tube 230; the function of the traction rope 240 is mainly to pull and guide the proximal end of the balloon body 110 into the recovery device 500 under the action of external force.

[0057] Furthermore, the through tube 220 has the same structure as the connecting tube 230 and is a hollow pipe that constitutes a part of the injection channel 221. The distal end of the through tube 220 is connected and communicated with the proximal end of the connecting tube 230, and the proximal end of the through tube 220 is connected to the distal end of the connector 210. The outer diameter of the through tube 220 is the same as the diameter of the connector 210.

[0058] Furthermore, the distal end of the connector 210 is connected to the proximal end of the through tube 220, and the port of the connector 210 (not marked in the figure) is the entrance and exit of the filler; a rubber plug 211 is provided inside the connector 210, and the main function of the rubber plug 211 is to completely close the inner cavity of the connector 210, so that the injection channel 221 is completely isolated from the outside world to prevent the filler from accidentally flowing out from the port of the connector 210; the diameter of the connector 210 is smaller than the diameter of the fluid channel 150; the function of the connector 210 is mainly to allow the needle end of the syringe containing the filler to pierce the rubber plug 211 from the port of the connector 210 and enter the injection channel 221, so that the filler can freely enter and exit the injection channel 221 through the syringe.

[0059] Optionally, the diameter of the injection channel 221 is 0.4-3.6 mm; the outer diameter of the through tube 220 is 0.8-4 mm; the outer diameter of the connecting tube 230 is 0.6-3 mm; and the diameter of the traction rope 240 is 0.05-2 mm.

[0060] Optionally, a drug coating is also provided on the outer surface of the balloon component 100 and the catheter component 200. The main function of the drug coating on the balloon component 100 is to inhibit the proliferation of vascular endothelial cells, smooth muscle cells and fibroblasts to reduce the restenosis after balloon dilation; and the main function of the drug coating on the catheter component 200 is to prevent the formation of thrombus on the outer surface of the catheter component 200 during the period when the catheter component 200 is retained in the blood vessel. The drug of the coating includes but is not limited to at least one of paclitaxel and rapamycin; the excipient (carrier) includes but is not limited to at least one of urea, iopromide, polysorbate, shellac, tri-n-hexyl butyryl citrate, tributyl acetyl citrate, magnesium stearate, and esters.

[0061] In this embodiment 1, the specific operation method of the above hollow balloon is as follows (refer to Figure 8 ):

[0062] refer to Figure 4 , the balloon assembly 100 of the hollow balloon is partially compressed and assembled at the distal end of the delivery device 300, that is, it is bound at the distal end of the delivery catheter 320 near the TIP head 310 end, and wrapped in the loading sleeve 330; a venous vascular access is established according to standard interventional techniques, and under the monitoring of a medical fluoroscopy device, the distal port of the guide sheath (not shown in the figure) is first pushed to the target blood vessel position through the venous vascular access through a guide wire, and then the TIP end of the delivery device 300 loaded with the hollow balloon is inserted into the guide sheath through the guide wire (at this time, the loading sleeve 330 is retracted and left outside the body), and the distal end of the delivery catheter 320 carrying the balloon assembly 100 is continued to be pushed out of the distal end of the guide sheath to reach the lesion blood vessel position.

[0063] The filling agent is injected into the injection channel 221 from the port of the connector 210 through a syringe and finally flows into the filling cavity 140 of the balloon body 110, so that the balloon assembly 100 is filled and expands radially. When the balloon assembly 100 is fully expanded, the drug coating on the outer surface of the balloon assembly 100 will contact the vessel wall of the diseased blood vessel, so that the drug coating is continuously absorbed by the vessel wall, and at the same time, blood is allowed to pass normally from the fluid channel 150 in the balloon assembly 100 (refer to Figure 5 , which is a schematic diagram of a treatment application scenario of a hollow balloon), that is, the hollow balloon can continuously treat diseased blood vessels for a period of time without affecting the blood flow therethrough; at this time, the drug coating on the outer surface of the catheter assembly 200 can also prevent the formation of thrombus on the outer surface of the catheter assembly 200.

[0064] After the balloon assembly 100 is expanded and supported at the location of the diseased blood vessel, other catheters or accessories are removed, leaving only the distal end of the balloon assembly 100 and the catheter assembly 200 in the blood vessel, and only the proximal end of the catheter assembly 200 in vitro (refer to Figure 6 ), fix the through tube 220 near the puncture point with a butterfly buckle 410, then thoroughly disinfect the skin around the puncture site and the proximal end of the catheter assembly 200, and then seal and fix the skin around the puncture site and the proximal end of the catheter assembly 200 with a sterile dressing 420 to fix and isolate airborne bacteria. Preferably, the hollow balloon continuously treats the blood vessel for 10 to 20 days (because the balloon assembly 100 stays in the blood vessel for a long time, thus avoiding the problems that the drug-coated balloons commonly used in the market only treat diseased blood vessels for a short time, such as vascular dissection, acute rebound of the vessel wall, and the short action time of the drug on the vessel wall, resulting in reduced efficacy); during this treatment process, pay attention to pipeline care.

[0065] After the treatment is completed, the sterile dressing 420 and the butterfly buckle 410 are removed. At this time, the proximal end of the catheter assembly 200 can be regarded as a "guide wire", that is, the guide sheath is passed through the proximal end of the catheter assembly 200 so that the distal end of the guide sheath can reach the vicinity of the proximal end of the balloon assembly 100; similarly, the retrieval device 500 (refer to Figure 7 ) through the proximal end of the catheter assembly 200 and the guide sheath, so that the distal end of the retrieval device 500 reaches the vicinity of the proximal end of the balloon assembly 100, and the outer tube 510 on the retrieval device 500 is withdrawn to expand the self-expanding storage net 530 at the distal end of the inner tube 520, and the filling agent in the balloon body 110 is extracted out of the body through the port of the connector 210 with a syringe, so that the balloon assembly 100 collapses and flattens and separates from the blood vessel wall, and the connector 210 is slowly pulled back to allow the balloon assembly 100 to enter the storage net 530 and the inner tube 520 lumen as a whole, and then the inner tube 520 is withdrawn to allow the storage net 530 to be completely returned to the outer tube 510, and then the retrieval device 500 is withdrawn from the blood vessel, and finally the wound care at the puncture site is performed. Example

[0066] refer to Fig. 9 This embodiment provides a hollow balloon. Compared with the embodiment 1, the hollow balloon has the same implementation method for treating blood vessels and uses the same material. The main difference is the structure of the balloon body 110'. The structure and molding method of the balloon body 110' in this embodiment are described below:

[0067] In a preferred embodiment, the balloon body 110' only includes a plurality of sub-balloons 111', and the balloon body 110' is a spiral structure formed by a long original balloon spirally wound around a central axis, and each spiral circle of the spiral structure constitutes a sub-balloon 111', and all sub-balloons 111' are interconnected; the sub-balloon 111' is a hollow ring-shaped structure, and all sub-balloons 111' are coaxially arranged, so that the inner circles of all sub-balloons 111' together constitute the fluid flow channel of the balloon body 110'; the distal ends of all traction ropes 240' and the connecting tubes 230' are arranged together on the proximal wall of the balloon body 110', and are arranged and connected at intervals along the circumference of the balloon body 110'.

[0068] A section of balloon tubing is heat blow molded on a balloon forming machine with a specific mold, so that a portion of the balloon tubing is formed into a long original balloon, and a section of the proximal balloon tubing is retained as a connecting tube 230'. The remaining balloon tubing portion at the distal end of the original balloon is cut off, and the incision is heat-shrink-sealed. The original balloon is then spirally wound around a central axis, and then the outer walls of two adjacent spiral turns are connected by gluing or other connecting methods to prevent the spiral structure from separating freely.

[0069] Optionally, the outer diameter of the balloon body 110 ′ is 5 to 25 mm; the length of the balloon body 110 ′ is 10 to 200 mm; and the cross-sectional diameter of the inner cavity of the daughter balloon 111 ′ is 0.5 to 2 mm.

Claims

1. A hollow balloon, comprising: A balloon assembly, the balloon assembly comprising a balloon body and a developing element, the balloon body comprising a plurality of sub-balloons, a plurality of flexible rings and a plurality of receiving ports; The sub-balloon is a hollow cylindrical structure, the flexible ring is a hollow annular structure, and a plurality of through holes are provided on the flexible ring; all the sub-balloons and the flexible rings are connected to each other in sequence, and all the sub-balloons and the flexible rings are coaxially arranged, so that the hollow structures of all the sub-balloons and all the flexible rings together constitute the fluid channel of the balloon body; the receiving port is arranged on the proximal edge of the balloon body; the outer surface of the balloon assembly is provided with a drug coating; the balloon assembly also includes a developing element, and the developing element is arranged on the balloon body. The two ends of the body are used to mark the position of the balloon assembly; the balloon body is composed of a hollow cylinder with a proximal end of a flexible ring connected to the distal end circumferentially, and the proximal end of the next hollow cylinder is connected to the distal end of the flexible ring, and similarly, other flexible rings and hollow cylinders are alternately connected end to end to form a tubular structure; each hollow cylinder constitutes a sub-balloon; each sub-balloon is also provided with an inner cavity, and all the inner cavities and all the through holes together constitute a filling cavity; and the filling cavity is isolated from the fluid channel; A catheter assembly, the catheter assembly includes a connecting tube, a plurality of traction ropes, a through tube and a joint; the distal end of the connecting tube is arranged on the proximal edge of the balloon body, and is interconnected and communicated with the balloon body, and the proximal end of the connecting tube is connected and communicated with the distal end of the through tube; the distal end of each of the traction ropes is arranged on the proximal edge of the balloon body, so that the distal end of the connecting tube and each of the connection points of the distal end of each of the traction ropes are respectively arranged circumferentially cross-arranged with the receiving port in sequence, the proximal end of each of the traction ropes and the proximal end of the connecting tube are gathered together and connected to the distal end of the through tube, and the proximal end of the through tube is connected to the joint; an injection channel is provided on the catheter assembly, and the injection channel is communicated with the inner cavity of all the sub-balloons and the through holes on all the flexible rings; the outer surface of the catheter assembly is provided with a drug coating.

2. The hollow balloon according to claim 1, characterized in that: The drug coating on the outer surfaces of the balloon component and the catheter component includes, but is not limited to, at least one of paclitaxel and rapamycin.

3. The hollow balloon according to claim 1, characterized in that: The compliant ring is a hollow annular structure, the through hole is located on the ring of the compliant ring, the opening direction of the through hole is consistent with the opening of the compliant ring, and the through hole intersects or is tangent to the ring of the compliant ring.

4. The hollow balloon according to claim 1, characterized in that: The number of the through holes on each of the compliant rings is no less than 2.

5. The hollow balloon according to claim 1, characterized in that: The shape of the storage opening is C-shaped, V-shaped, rectangular or square, and the number of the storage openings is not less than 3.

6. The hollow balloon according to claim 1, characterized in that: The material of the balloon component and the catheter component includes but is not limited to at least one of nylon (PA), polyether block polyamide (Pebax), polyurethane (PU) or polyethylene terephthalate (PET).

7. The hollow balloon according to claim 1, characterized in that: The outer diameter of the balloon body is 5 to 25 mm; the length of the balloon body is 10 to 200 mm; the cross-sectional diameter of the inner cavity of the sub-balloon is 0.5 to 2 mm; the cross-sectional diameter of the through hole is 0.5 to 2 mm; and the length of the through hole is 0.5 to 5 mm.

8. The hollow balloon according to claim 1, characterized in that: The diameter of each traction rope is not greater than the outer diameter of the connecting pipe, the outer diameter of the connecting pipe is not greater than the outer diameter of the through pipe, the outer diameter of the through pipe is the same as the diameter of the joint, and the diameter of the joint is smaller than the diameter of the fluid channel.

9. The hollow balloon according to claim 8, characterized in that: The traction rope is a solid strip structure, and the number of the traction ropes is not less than 2.

10. The hollow balloon according to claim 1, characterized in that: The number of the connecting pipes is not less than one.

11. The hollow balloon according to claim 1, characterized in that: A rubber plug is arranged in the joint, and the rubber plug is tightly combined with the inner cavity of the joint.

12. The hollow balloon according to claim 1, characterized in that: The diameter of each sub-balloon on the balloon assembly is the same. Similarly, the diameter of each flexible ring is the same, that is, the channel diameters of each section of the entire fluid channel are the same.

13. The hollow balloon according to claim 1, characterized in that: The diameter of each sub-balloon on the balloon assembly is different. Similarly, the diameter of each flexible ring is different, that is, the channel diameters of each section of the entire fluid channel are different.

14. The hollow balloon according to claim 1, characterized in that: The balloon body only includes multiple sub-balloons, and the balloon body is a spiral structure formed by a long original balloon spirally wound around a central axis. Each spiral circle of the spiral structure constitutes a sub-balloon, and all the sub-balloons are interconnected. The sub-balloons are hollow ring-shaped structures, and all the sub-balloons are coaxially arranged, so that the inner circles of all the sub-balloons together constitute the fluid flow channel of the balloon body.